Viridian Therapeutics Current Assets

As of the most recent data (June 2026), VRDN shows a current assets of $1.1B. That compares with $580M in the prior-year period — up 86.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VRDN's current assets is now $1.1B (was $580M) — a 86.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Viridian Therapeutics is outperforming or lagging.

Tracking VRDN's current assets over time shows whether Viridian Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B That compares with $580M in the prior-year period — up 86.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Viridian Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.1B) with ownership activity and broader fundamentals.

Viridian Therapeutics's current assets is $1.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.